---
title: "Company"
id: "198"
type: "page"
slug: "company"
published_at: "2025-07-09T14:23:30+00:00"
modified_at: "2026-03-20T09:38:29+00:00"
url: "https://innocorepharma.com/company/"
markdown_url: "https://innocorepharma.com/company.md"
---

Company

# Unlocking the potential of long-acting injectables for todays and tomorrows peptide and biologic therapeutics

We are a global leader in drug delivery development for formulating peptides and complex biologics into tunable, biodegradable and scalable long-acting injectable (LAI) dosage forms.

Our best-in-class proprietary polymeric drug delivery platform, SynBiosys®, overcomes the significant technical challenges of formulating complex and fragile APIs into LAI drug products and is designed to optimise their therapeutic performance, reduce dosing frequency and add value.

The Innocore team of formulation and development experts is driving innovation for better patient outcomes.

[Formulation Development Partner for Long-Acting Injectables – Innocore Discover more](https://innocorepharma.com/company/partnering-with-innocore/)
[People A world class, multinational team Discover more](https://innocorepharma.com/company/people/)
[Careers Come and join us at InnoCore! Discover more](https://innocorepharma.com/company/careers/)

## Our Core Values

### Scientific excellence

This is the foundation of everything we do at Innocore. With over 20 years of expertise in polymer science and drug formulation, we’ve developed a best-in-class technology, SynBiosys®, that overcomes the challenges of biologic and peptide drug product formulation.

### Agility

The Innocore team can rapidly adapt to a partner’s needs and project complexities throughout the pharmaceutical development journey. We offer tailored and creative solutions to optimise formulation performance and shorten timelines whether your project is big or small, preclinical or clinical.

### Close collaboration

We work hand-in-hand with our partners, from large pharma to small biotechs and NGOs. We act as an extension of your team and can align seamlessly with diverse regulatory, technical and strategic requirements.

### Future-proofing

We anticipate the needs of our partners and the market. As therapeutic demands evolve, we ensure our technical solutions remain adaptable, easy-to-scale, and competitive, enabling the seamless progression from clinical development through to market readiness.

### The Company in numbers

>20 years

Proven track record

1500m²

Office, R&D & production facility

45

Number of employees

More About Innocore

[About Explore Innocore](https://innocorepharma.com/company/)

[Technologies Discover our technologies](https://innocorepharma.com/technologies/)

[Partnering Partner with us](https://innocorepharma.com/company/partnering-with-innocore/)